Acute and chronic safety and efficacy of dose dependent creatine nitrate supplementation and exercise performance.
Additional Document Info
BACKGROUND: Creatine monohydrate (CrM) and nitrate are popular supplements for improving exercise performance; yet have not been investigated in combination. We performed two studies to determine the safety and exercise performance-characteristics of creatine nitrate (CrN) supplementation. METHODS: Study 1 participants (N=13) ingested 1.5g CrN (CrN-Low), 3g CrN (CrN-High), 5g CrM or a placebo in a randomized, crossover study (7d washout) to determine supplement safety (hepatorenal and muscle enzymes, heart rate, blood pressure and side effects) measured at time-0 (unsupplemented), 30-min, and then hourly for 5-h post-ingestion. Study 2 participants (N=48) received the same CrN treatments vs. 3g CrM in a randomized, double-blind, 28d trial inclusive of a 7-d interim testing period and loading sequence (4 servings/d). Day-7 and d-28 measured Tendo bench press performance, Wingate testing and a 6x6-s bicycle ergometer sprint. Data were analyzed using a GLM and results are reported as meanSD or mean change95% CI. RESULTS: In both studies we observed several significant, yet stochastic changes in blood markers that were not indicative of potential harm or consistent for any treatment group. Equally, all treatment groups reported a similar number of minimal side effects. In Study 2, there was a significant increase in plasma nitrates for both CrN groups by d-7, subsequently abating by d-28. Muscle creatine increased significantly by d-7 in the CrM and CrN-High groups, but then decreased by d-28 for CrN-High. By d-28, there were significant increases in bench press lifting volume (kg) for all groups (PLA, 126.6, 95% CI 26.3, 226.8; CrM, 194.1, 95% CI 89.0, 299.2; CrN-Low, 118.3, 95% CI 26.1, 210.5; CrN-High, 267.2, 95% CI 175.0, 359.4, kg). Only the CrN-High group was significantly greater than PLA (p<0.05). Similar findings were observed for bench press peak power (PLA, 59.0, 95% CI 4.5, 113.4; CrM, 68.6, 95% CI 11.4, 125.8; CrN-Low, 40.9, 95% CI -9.2, 91.0; CrN-High, 60.9, 95% CI 10.8, 111.1, W) and average power. CONCLUSIONS: Creatine nitrate delivered at 3g was well-tolerated, demonstrated similar performance benefits to 3g CrM, in addition, within the confines of this study, there were no safety concerns.
Galvan, E., Walker, D. K., Simbo, S. Y., Dalton, R., Levers, K., O'Connor, A., ... Kreider, R. B.
complete list of authors
Galvan, Elfego||Walker, Dillon K||Simbo, Sunday Y||Dalton, Ryan||Levers, Kyle||O'Connor, Abigail||Goodenough, Chelsea||Barringer, Nicholas D||Greenwood, Mike||Rasmussen, Christopher||Smith, Stephen B||Riechman, Steven E||Fluckey, James D||Murano, Peter S||Earnest, Conrad P||Kreider, Richard B